Alopecia universalis in an adult after routine tetanus toxoid vaccine

被引：8
作者：
Sanchez-Ramon, Silvia [1 ]
Gil, Juana [1 ]
Cianchetta-Sivori, Malena [1 ]
Fernandez-Cruz, Eduardo [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Dept Inmunol, Madrid, Spain
来源：
MEDICINA CLINICA | 2011年 / 136卷 / 07期
关键词：
IMMUNIZATION; AREATA;
D O I：
10.1016/j.medcli.2010.03.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：318 / 318
页数：1
相关论文
共 50 条
  • [31] Tetanus After Vaccine Refusal and an Opportunity for the Pediatric Infectious Diseases Specialist
    Douvoyiannis, Miltiadis
    Belamarich, Peter F.
    Goldman, David L.
    CLINICAL PEDIATRICS, 2015, 54 (06) : 513 - 516
  • [32] Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone
    Sanni Yaya
    Komlan Kota
    Amos Buh
    Ghose Bishwajit
    BMC Public Health, 20
  • [33] Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone
    Yaya, Sanni
    Kota, Komlan
    Buh, Amos
    Bishwajit, Ghose
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [34] Dose-response to type V group B streptococcal poly saccharide-tetanus toxoid conjugate vaccine in healthy adults
    Baker, Carol J.
    Rench, Marcia A.
    Paoletti, Lawrence C.
    Edwards, Morven S.
    VACCINE, 2007, 25 (01) : 55 - 63
  • [35] Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine
    Vesikari, Timo
    Forsten, Aino
    Bianco, Veronique
    Van der Wielen, Marie
    Miller, Jacqueline M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (01) : 132 - 139
  • [36] Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-adjuvanted Vaccine Coadministered With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine and/or Meningococcal Conjugate Vaccine to Healthy Girls 11 to 18 Years of Age Results From a Randomized Open Trial
    Wheeler, Cosette M.
    Harvey, Bryan M.
    Pichichero, Michael E.
    Simon, Michael W.
    Combs, Stephen P.
    Blatter, Mark M.
    Marshall, Gary S.
    Catteau, Gregory
    Dobbelaere, Kurt
    Descamps, Dominique
    Dubin, Gary
    Schuind, Anne
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (12) : E225 - E234
  • [37] A multi-centre, post-marketing surveillance study of Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar TCV®) in India
    Reddy, Raghu
    Reddy, Bhargav
    Sarangi, Vamshi
    Reddy, Siddharth
    Ella, Raches
    Vadrevu, Krishna Mohan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [38] Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines
    Vesikari, Timo
    Forsten, Aino
    Bianco, Veronique
    Van der Wielen, Marie
    Miller, Jacqueline M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (12) : E298 - E307
  • [39] Trends and determinants of taking tetanus toxoid vaccine among women during last pregnancy in Bangladesh: Country representative survey from 2006 to 2019
    Amin, Bony
    Roy, Nitai
    Meem, Amatul Elah
    Hossain, Ekhtear
    Aktarujjaman
    PLOS ONE, 2022, 17 (10):
  • [40] Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence
    Assaf-Casals, Aia
    Dbaibo, Ghassan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (07) : 1825 - 1837
12345